These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32305587)

  • 21. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
    Chatterjee P; Anand T; Singh KJ; Rasaily R; Singh R; Das S; Singh H; Praharaj I; Gangakhedkar RR; Bhargava B; Panda S
    Indian J Med Res; 2020 May; 151(5):459-467. PubMed ID: 32611916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
    Yu B; Li C; Chen P; Zhou N; Wang L; Li J; Jiang H; Wang DW
    Sci China Life Sci; 2020 Oct; 63(10):1515-1521. PubMed ID: 32418114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Rathi S; Ish P; Kalantri A; Kalantri S
    Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
    [No Abstract]   [Full Text] [Related]  

  • 24. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Principi N; Esposito S
    Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
    Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
    Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
    ; Horby P; Mafham M; Linsell L; Bell JL; Staplin N; Emberson JR; Wiselka M; Ustianowski A; Elmahi E; Prudon B; Whitehouse T; Felton T; Williams J; Faccenda J; Underwood J; Baillie JK; Chappell LC; Faust SN; Jaki T; Jeffery K; Lim WS; Montgomery A; Rowan K; Tarning J; Watson JA; White NJ; Juszczak E; Haynes R; Landray MJ
    N Engl J Med; 2020 Nov; 383(21):2030-2040. PubMed ID: 33031652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
    Mercuro NJ; Yen CF; Shim DJ; Maher TR; McCoy CM; Zimetbaum PJ; Gold HS
    JAMA Cardiol; 2020 Sep; 5(9):1036-1041. PubMed ID: 32936252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
    Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
    Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
    Konig MF; Kim AH; Scheetz MH; Graef ER; Liew JW; Simard J; Machado PM; Gianfrancesco M; Yazdany J; Langguth D; Robinson PC;
    Ann Rheum Dis; 2020 Oct; 79(10):1386-1388. PubMed ID: 32381561
    [No Abstract]   [Full Text] [Related]  

  • 30. Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness.
    Al-Kofahi M; Jacobson P; Boulware DR; Matas A; Kandaswamy R; Jaber MM; Rajasingham R; Young JH; Nicol MR
    Clin Pharmacol Ther; 2020 Oct; 108(4):766-769. PubMed ID: 32344449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
    Lofgren SM; Nicol MR; Bangdiwala AS; Pastick KA; Okafor EC; Skipper CP; Pullen MF; Engen NW; Abassi M; Williams DA; Nascene AA; Axelrod ML; Lother SA; MacKenzie LJ; Drobot G; Marten N; Cheng MP; Zarychanski R; Schwartz IS; Silverman M; Chagla Z; Kelly LE; McDonald EG; Lee TC; Hullsiek KH; Boulware DR; Rajasingham R
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa500. PubMed ID: 33204764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
    Carafoli E
    Biochem Biophys Res Commun; 2021 Jan; 538():156-162. PubMed ID: 33028485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
    Ayerbe L; Risco-Risco C; Ayis S
    Intern Emerg Med; 2020 Nov; 15(8):1501-1506. PubMed ID: 32997237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
    Albani F; Fusina F; Giovannini A; Ferretti P; Granato A; Prezioso C; Divizia D; Sabaini A; Marri M; Malpetti E; Natalini G
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32872629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
    Catteau L; Dauby N; Montourcy M; Bottieau E; Hautekiet J; Goetghebeur E; van Ierssel S; Duysburgh E; Van Oyen H; Wyndham-Thomas C; Van Beckhoven D;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106144. PubMed ID: 32853673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak.
    Singh S; Kaur R; Singh RK
    Aging Clin Exp Res; 2020 Aug; 32(8):1609-1612. PubMed ID: 32797388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
    Wiseman DM
    Int J Infect Dis; 2020 Oct; 99():344-345. PubMed ID: 32768694
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
    Kalligeros M; Shehadeh F; Atalla E; Mylona EK; Aung S; Pandita A; Larkin J; Sanchez M; Touzard-Romo F; Brotherton A; Shah R; Cunha CB; Mylonakis E
    J Glob Antimicrob Resist; 2020 Sep; 22():842-844. PubMed ID: 32763357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
    d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
    Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.